Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxygenator, which increases oxygen in the blood stream; and products for reducing facial wrinkles. The company distributes its products through health food stores, pharmacies, and various other retail outlets throughout the United States and internationally. Emergent Health Corp. was incorporated in 2006 and is based in King of Prussia, Pennsylvania. As of August 26, 2014, Emergent Health Corp was taken private.
Часто задаваемые вопросы
В каком секторе работает Emergent Health Corp (EMGE)?
Emergent Health Corp относится к сектору Здравоохранение.
Какова текущая цена акций Emergent Health Corp (EMGE)?
По последним данным, цена акций Emergent Health Corp составляет 0,00 $, предыдущее закрытие — 0,00 $.
Выплачивает ли Emergent Health Corp (EMGE) дивиденды?
Нет, Emergent Health Corp не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Emergent Health Corp (EMGE)?
У компании Emergent Health Corp бета -57.781, что указывает на более низкую волатильность по сравнению с рынком в целом.
